Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy.
Saved in:
| Title: | Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy. |
|---|---|
| Authors: | Qin, Ya-Zhen1 (AUTHOR), Xu, Lan-Ping1 (AUTHOR), Chen, Huan1 (AUTHOR), Jiang, Qian1 (AUTHOR), Wang, Yu1 (AUTHOR), Jiang, Hao1 (AUTHOR), Zhang, Xiao-Hui1 (AUTHOR), Han, Wei1 (AUTHOR), Chen, Yu-Hong1 (AUTHOR), Wang, Feng-Rong1 (AUTHOR), Wang, Jing-Zhi1 (AUTHOR), Zhu, Hong-Hu1 (AUTHOR), Liu, Yan-Rong1 (AUTHOR), Jiang, Bin1 (AUTHOR), Liu, Kai-Yan1 (AUTHOR), Huang, Xiao-Jun1,2 (AUTHOR) xjhrm@medmail.com.cn |
| Source: | Leukemia & Lymphoma. Nov2015, Vol. 56 Issue 11, p3116-3123. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
